XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
6 Months Ended
Apr. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill balances and movements for each reportable segment during the period
The following table presents goodwill balances and the movements for each of our reportable segments during the six months ended April 30, 2022:
 
 Life Sciences and Applied MarketsDiagnostics and GenomicsAgilent CrossLabTotal
 (in millions)
Goodwill as of October 31, 2021$1,743 $1,964 $268 $3,975 
Foreign currency translation impact(7)(7)(5)(19)
Goodwill as of April 30, 2022$1,736 $1,957 $263 $3,956 
Components of other intangible assets during the period
The component parts of other intangible assets as of April 30, 2022 and October 31, 2021 are shown in the table below:
 
 Other Intangible Assets
 Gross
Carrying
Amount
Accumulated
Amortization
Net Book
Value
 (in millions)
As of October 31, 2021   
Purchased technology$1,742 $972 $770 
Trademark/Tradename196 133 63 
Customer relationships357 228 129 
Backlog
Third-party technology and licenses11 
Total amortizable intangible assets2,314 1,344 970 
In-Process R&D11 — 11 
Total$2,325 $1,344 $981 
As of April 30, 2022   
Purchased technology$1,737 $1,024 $713 
Trademark/Tradename196 141 55 
Customer relationships354 261 93 
Backlog
Third-party technology and licenses33 24 
Total amortizable intangible assets2,328 1,440 888 
In-Process R&D10 — 10 
Total$2,338 $1,440 $898 
Schedule of estimated future amortization expense of finite-lived intangible assets
Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2022 and for each of the next five fiscal years and thereafter is estimated below:
Estimated future amortization expense:
(in millions)
Remainder of 2022$90 
2023$143 
2024$125 
2025$100 
2026$70 
2027$69 
Thereafter$291